Second generation of cryoballoons can improve efficiency of cryoablation for atrial fibrillation. - Wikidata - wikimedia - TriplyDB

Second generation of cryoballoons can improve efficiency of cryoablation for atrial fibrillation.

Second generation of cryoballoons can improve efficiency of cryoablation for atrial fibrillation.

http://www.wikidata.org/entity/Q41705368

about

Cryoballoon ablation of atrial fibrillation: a practical and effective approach Safety and Efficacy of Different Catheter Ablations for Atrial Fibrillation: A Systematic Review and Meta-Analysis.Safety and efficacy of second-generation versus first-generation cryoballoons for treatment of atrial fibrillation: a meta-analysis of current evidence.Efficacy and safety of the second-generation cryoballoons versus radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: a systematic review and meta-analysis.Comparison of catheter ablation for paroxysmal atrial fibrillation between cryoballoon and radiofrequency: a meta-analysis.Outcomes Of Cryoballoon Ablation Of Atrial Fibrillation: A Comprehensive Review Comparison between First- and Second-Generation Cryoballoon for Paroxysmal Atrial Fibrillation Ablation.One-Year Clinical Outcome of Pulmonary Vein Isolation Using the Second-Generation Cryoballoon: A Meta-Analysis.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Long-term outcome after second-generation cryoballoon ablation for paroxysmal atrial fibrillation - a 3-years follow-up.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

P2860

Q28067645-EB1D5B48-E181-4E47-B6B9-754C0CDC2A48 Q30250268-05344457-B742-48C0-A536-063D5B54D791 Q35845910-8FC033E0-8777-4E1A-B412-86E0FA29F642 Q36147511-7EC9842A-BEDE-41A3-804D-001A5A9E4B13 Q36243633-8C264D93-4A25-4104-88E9-CA1AC6DE5B22 Q39037117-8DA421FB-433E-4D35-8F68-007890249D91 Q39649344-9857DBBA-07F0-4F8B-9414-A0AE02A73092 Q40290849-F3D11FEF-E62A-4B43-8B8F-79D56128EBD9 Q45059153-97EDC217-8075-48A8-90C5-3D9330B3DE45 Q46658026-0691D8A9-BF5A-4405-AFDC-F49D647F0517 Q53748027-088A1DA3-D791-4E7B-8CE7-096460DC0A77 Q55263071-27369B32-1A6C-49A5-AD42-63C1687DADDF

P2860

Second generation of cryoballoons can improve efficiency of cryoablation for atrial fibrillation.

http://www.wikidata.org/entity/Q41705368

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Second generation of cryoballo ...... ation for atrial fibrillation.

@en

type

label

Second generation of cryoballo ...... ation for atrial fibrillation.

@en

prefLabel

Second generation of cryoballo ...... ation for atrial fibrillation.

@en

P1433

Q41705368-BFEA67AD-6E3F-4713-8B7A-1307904A9A27

P1476

Q41705368-EEA86997-81C3-4BC7-8AE9-AFBED0CEDAC2

P2093

Q41705368-1FFFFBB8-7EB2-4EDF-B9E3-B5019EE77AE8

Q41705368-222BF8F0-1881-49A8-BBB5-664322E37E8E

Q41705368-444A39C9-D16E-49E3-820D-488ECC63E4A6

Q41705368-C07B8135-7BE2-4764-90B0-80F6AC43C29C

Q41705368-CACDF964-B6A1-4CC5-9C4A-295492A70514

P2860

Q41705368-1078CC60-426F-4A00-9F1D-38FEEDAD0C04

Q41705368-15872628-A54F-4F15-9629-BB6481F1DBDD

Q41705368-34040D19-9831-4B5C-AD67-E0CE4613EEE0

Q41705368-3B303749-3731-47CE-A86E-72066279F14B

Q41705368-5D6381BE-FA68-497C-8C7E-816DC64A6F39

Q41705368-B1D3CCFF-725D-4BEB-B90D-4E80CFE4633B

Q41705368-DCAF920D-BB75-47F2-9B9F-FEA775F3AD4B

Q41705368-E5EC2E01-F1DF-4745-86CF-AC4F123C5DBB

Q41705368-FBE3604F-5037-4B06-865F-1F1DE00BA588

P304

Q41705368-0E56BED7-C95F-45E3-BAED-97C326C3372B

P31

Q41705368-B560222C-6F77-49E0-97CC-E873251191A8

P356

Q41705368-5F121D92-759F-41B1-972B-B35687BA27DC

P433

Q41705368-5B0B626E-B014-4B80-ACC3-74BE51B2DBD7

P478

Q41705368-96E42306-5228-4A12-BF75-8B59D4FEAADA

P577

Q41705368-C3203FA6-3D44-4472-A111-1CEA07F71D3B

P698

Q41705368-1F2238F9-B07B-49B3-9EC6-1B6EF3F294EF

P356

P1433

Pacing and Clinical Electrophysiology

P1476

Second generation of cryoballo ...... ation for atrial fibrillation.

@en

P2093

Charalampos Kriatselis

http://www.w3.org/2001/XMLSchema#string

Eckart Fleck

http://www.w3.org/2001/XMLSchema#string

Jan Kaufmann

http://www.w3.org/2001/XMLSchema#string

Jin Hong Gerds-Li

http://www.w3.org/2001/XMLSchema#string

Jun Liu

http://www.w3.org/2001/XMLSchema#string

P2860

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon.

The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon.

A novel cryoballoon technique for mapping and isolating pulmonary veins: a feasibility and efficacy study.

Inner lumen mapping catheter-facilitated big cryoballoon treatment for atrial fibrillation shortens procedural duration and fluoroscopic exposure with comparable mid-term efficacy.

Intraprocedural imaging of left atrium and pulmonary veins: a comparison study between rotational angiography and cardiac computed tomography.

Optimal fluoroscopic projections for angiographic imaging of the pulmonary vein ostia: lessons learned from the intraprocedural reconstruction of the left atrium and pulmonary veins.

One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon.

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design:

P304

129-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PACE.12538

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25494851

http://www.w3.org/2001/XMLSchema#string